Boryung Sustainability Profile
Boryung, officially known as Boryung Pharmaceutical Co., Ltd., is a prominent player in the pharmaceutical industry, headquartered in South Korea (KR). Established in 1963, the company has made significant strides in developing innovative healthcare solutions, particularly in the fields of pharmaceuticals and biotechnology. With a strong presence in both domestic and international markets, Boryung focuses on a diverse range of therapeutic areas, including oncology, cardiology, and infectious diseases. Its core products, which include advanced biopharmaceuticals and generics, are distinguished by their high quality and efficacy. Boryung has achieved notable milestones, such as expanding its global footprint and securing partnerships with leading research institutions. This commitment to innovation and excellence has solidified its position as a trusted name in the healthcare sector, making significant contributions to improving patient outcomes worldwide.
DitchCarbon Score
How does Boryung's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Boryung's score of 29 is lower than 51% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Boryung's reported carbon emissions
In 2023, Boryung reported total carbon emissions of approximately 27,457,000 kg CO2e, encompassing Scope 1 and 2 emissions. This figure reflects a slight decrease from 2022, where emissions were about 27,499,000 kg CO2e. The company has shown a progressive reduction in emissions over the years, with 2021 emissions recorded at approximately 24,857,000 kg CO2e and 2020 emissions at about 26,482,000 kg CO2e, which included 3,906,000 kg CO2e from Scope 1 and 22,623,000 kg CO2e from Scope 2. Despite these reductions, Boryung has not disclosed any specific reduction targets or initiatives under the Science Based Targets initiative (SBTi) or other climate pledges. The absence of detailed Scope 3 emissions data indicates a potential area for future reporting and improvement. Boryung's emissions data is sourced directly from Boryung Corporation, with no cascading from a parent or related organization. Overall, Boryung's commitment to reducing its carbon footprint is evident through its decreasing emissions trend, although further transparency regarding specific targets and broader emissions scopes would enhance its climate strategy.
Unlock detailed emissions data
Access structured emissions data, company-specific emission factors, and source documents
| 2020 | 2021 | 2022 | 2023 | |
|---|---|---|---|---|
| Scope 1 | 3,906,000 | - | - | - |
| Scope 2 | 22,623,000 | - | - | - |
| Scope 3 | - | - | - | - |
How Carbon Intensive is Boryung's Industry?
How Carbon Intensive is Boryung's Location?
Boryung's Climate Goals (2030 & 2050)
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
Boryung has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.
